12 July 2024
Assura plc
("the Company")
Exercise of Nil Cost Options under PSP
Assura plc ("Assura"), the specialist healthcare property investor and developer announces that on 10 July 2024, the PDMRs listed below exercised their 2021 PSP awards.
The table below shows the number of shares vesting, the number of shares sold to satisfy income tax and national insurance liabilities, the number of shares sold for the benefit of the Assura Community Fund and the number of shares received following the sales.
| | Number of shares awarded | Number of shares sold to satisfy income tax and national insurance liabilities | Additional shares sold on behalf of the Assura Community Fund | Additional shares sold | Number of shares after shares sold |
| Jonathan Murphy | 392,165 | 184,317 | 39,217 | - | 168,631 |
| Jayne Cottam | 220,406 | 103,591 | - | - | 116,815 |
| Orla Ball | 52,903 | 24,864 | - | 28,039 | - |
The Remuneration Committee of Assura had agreed that sufficient shares may be sold by each PDMR to cover the arising income tax and national insurance liabilities, that Mr Murphy could sell 39,217 shares to make a contribution to the Assura Community Fund and that Ms Ball could sell the balances of her restricted shares in full. The relevant market price for taxation purposes is £0.4229 per share.
As a result of the above, the PDMR's shareholding and those of their connected persons is as follows:
| | Shareholding on 9 July 2024
| Shareholding post exercise |
| Jonathan Murphy | 3,149,294 | 3,317,925 |
| Jayne Cottam | 826,255 | 943,070 |
| Orla Ball | 29,768 | 29,768 |
Following the allotment, Mr Murphy & Ms Cottam transferred 168,630 and 116,815 shares respectively to their spouse. The total beneficial holding remains the same.
The Notification of Dealing Forms can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification of dealing form
| 1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||||
| a) | Name
| Jonathan Murphy | ||||||
| 2 | Reason for the notification
| |||||||
| a) | Position/status
| CEO | ||||||
| b) | Initial notification/ Amendment
| Initial notification | ||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||
| a) | Name
| Assura plc | ||||||
| b) | LEI
| 21380026T19N2Y52XF72 | ||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||||
| b) | Nature of the transaction
| Vesting of share awards under PSP | ||||||
| c) | Price(s) and volume(s)
|
| ||||||
| d) | Aggregated information
- Aggregated volume
- Price
|
N/A | ||||||
| e) | Date of the transaction
| 10/07/2024 | ||||||
| f) | Place of the transaction
| XLON | ||||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||||
| b) | Nature of the transaction
| Sale of shares to satisfy tax and national insurance liabilities and to make a contribution to the Assura Community Fund. | ||||||
| c) | Price(s) and volume(s)
|
| ||||||
| d) | Aggregated information
- Aggregated volume
- Price
|
| ||||||
| e) | Date of the transaction
| 10/07/2024 | ||||||
| f) | Place of the transaction
| XLON | ||||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||||
| b) | Nature of the transaction
| Transfer shares to Mr Murphy's spouse | ||||||
| c) | Price(s) and volume(s)
|
| ||||||
| d) | Aggregated information
- Aggregated volume
- Price
|
| ||||||
| e) | Date of the transaction
| 10/07/2024 | ||||||
| f) | Place of the transaction
| XLON | ||||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||||
| a) | Name
| Jayne Cottam | ||||||
| 2 | Reason for the notification
| |||||||
| a) | Position/status
| CFO | ||||||
| b) | Initial notification/ Amendment
| Initial notification | ||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||
| a) | Name
| Assura plc | ||||||
| b) | LEI
| 21380026T19N2Y52XF72 | ||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||||
| b) | Nature of the transaction
| Vesting of share awards under PSP | ||||||
| c) | Price(s) and volume(s)
|
| ||||||
| d) | Aggregated information
- Aggregated volume
- Price
|
N/A | ||||||
| e) | Date of the transaction
| 10/07/2024 | ||||||
| f) | Place of the transaction
| XLON | ||||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||||
| b) | Nature of the transaction
| Sale of shares to satisfy tax and national insurance liabilities. | ||||||
| c) | Price(s) and volume(s)
|
| ||||||
| d) | Aggregated information
- Aggregated volume
- Price
|
| ||||||
| e) | Date of the transaction
| 10/07/2024 | ||||||
| f) | Place of the transaction
| XLON | ||||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||||
| b) | Nature of the transaction
| Transfer shares to Ms Cottam's spouse | ||||||
| c) | Price(s) and volume(s)
|
| ||||||
| d) | Aggregated information
- Aggregated volume
- Price
|
| ||||||
| e) | Date of the transaction
| 10/07/2024 | ||||||
| f) | Place of the transaction
| XLON | ||||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||||
| a) | Name
| Orla Ball | ||||||
| 2 | Reason for the notification
| |||||||
| a) | Position/status
| General Counsel | ||||||
| b) | Initial notification/ Amendment
| Initial notification | ||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||
| a) | Name
| Assura plc | ||||||
| b) | LEI
| 21380026T19N2Y52XF72 | ||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||||
| b) | Nature of the transaction
| Vesting of restricted share awards under PSP | ||||||
| c) | Price(s) and volume(s)
|
| ||||||
| d) | Aggregated information
- Aggregated volume
- Price
|
N/A | ||||||
| e) | Date of the transaction
| 10/07/2024 | ||||||
| f) | Place of the transaction
| XLON | ||||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||||
| b) | Nature of the transaction
| Sale of shares to satisfy tax and national insurance liabilities. | ||||||
| c) | Price(s) and volume(s)
|
| ||||||
| d) | Aggregated information
- Aggregated volume
- Price
|
| ||||||
| e) | Date of the transaction
| 10/07/2024 | ||||||
| f) | Place of the transaction
| XLON | ||||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||||
| b) | Nature of the transaction
| Sale of shares | ||||||
| c) | Price(s) and volume(s)
|
| ||||||
| d) | Aggregated information
- Aggregated volume
- Price
|
| ||||||
| e) | Date of the transaction
| 10/07/2024 | ||||||
| f) | Place of the transaction
| XLON | ||||||
- Ends -
For more information, please contact:
|
Assura plc |
Tel: 0161 515 2043 |
| Orla Ball, General Counsel David Purcell, Investor Relations Director
| Email: Investor@assura.co.uk |
| FGS Global Gordon Simpson | Tel: 0207 251 3801 Email: Assura@fgsglobal.com |
Notes to Editors
Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.
A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.
At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
